Prostate cancer (PC) is the most common malignancy in men. Common characteristic involved in PC pathogenesis are disturbed lipid metabolism and abnormal cholesterol accumulation. Cholesterol can be further utilized for membrane or hormone synthesis while cholesterol biosynthesis intermediates are important for oncogene membrane anchoring, nucleotide synthesis and mitochondrial electron transport. Since cholesterol and its biosynthesis intermediates influence numerous cellular processes, in this review we have described cholesterol homeostasis in a normal cell. Additionally, we have illustrated how commonly deregulated signaling pathways in PC (PI3K/AKT/MTOR, MAPK, AR and p53) are linked with cholesterol homeostasis regulation
SummaryAltered lipid metabolism is increasingly recognized as a signature of cancer cells. Enabled b...
De novo lipogenesis of cholesterol and fatty acids is a well-described AR-regulated metabolic pathwa...
Elevated circulating cholesterol is a systemic risk factor for cardiovascular disease and metabolic ...
Prostate cancer (PC) is the most common malignancy in men. Common characteristic involved in PC path...
BACKGROUND:Recently, there has been renewed interest in the link between cholesterol and prostate ca...
Prostate cancer (PCa) is the most common cancer in men in developed countries. Epidemiological studi...
, prostate cancer cells lack sterol-mediated feedback regulation of the major transcription factor i...
Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an i...
International audienceCholesterol is a fundamental molecule for life. Located in the cell membrane, ...
Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an i...
Background The relationship between cholesterol and prostate cancer has been extensively studied for...
Cholesterol-lowering treatment has been suggested to delay progression of prostate cancer by decreas...
<div><p>Cholesterol-lowering treatment has been suggested to delay progression of prostate cancer by...
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate...
Cholesterol-enriched domains are nowadays proposed to contribute to cancer cell proliferation, survi...
SummaryAltered lipid metabolism is increasingly recognized as a signature of cancer cells. Enabled b...
De novo lipogenesis of cholesterol and fatty acids is a well-described AR-regulated metabolic pathwa...
Elevated circulating cholesterol is a systemic risk factor for cardiovascular disease and metabolic ...
Prostate cancer (PC) is the most common malignancy in men. Common characteristic involved in PC path...
BACKGROUND:Recently, there has been renewed interest in the link between cholesterol and prostate ca...
Prostate cancer (PCa) is the most common cancer in men in developed countries. Epidemiological studi...
, prostate cancer cells lack sterol-mediated feedback regulation of the major transcription factor i...
Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an i...
International audienceCholesterol is a fundamental molecule for life. Located in the cell membrane, ...
Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an i...
Background The relationship between cholesterol and prostate cancer has been extensively studied for...
Cholesterol-lowering treatment has been suggested to delay progression of prostate cancer by decreas...
<div><p>Cholesterol-lowering treatment has been suggested to delay progression of prostate cancer by...
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate...
Cholesterol-enriched domains are nowadays proposed to contribute to cancer cell proliferation, survi...
SummaryAltered lipid metabolism is increasingly recognized as a signature of cancer cells. Enabled b...
De novo lipogenesis of cholesterol and fatty acids is a well-described AR-regulated metabolic pathwa...
Elevated circulating cholesterol is a systemic risk factor for cardiovascular disease and metabolic ...